Investing in a vaccine for COVID-19 - "molecular clamp" technology, which allows new vaccines to be developed within months, rather than years, in response to emerging diseases.
- Funded by Australian Government (Australian Research Council)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$9,068,000Funder
Australian Government (Australian Research Council)Research Location
AustraliaLead Research Institution
University of QueenslandResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Vaccine design and administrationSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
Investing in a vaccine for COVID-19 - "molecular clamp" technology, which allows new vaccines to be developed within months, rather than years, in response to emerging diseases.